Genmab
GMAB
$27.22
Share price
0.83%
Change (1 day)
-32.96%
Change (1 year)
Categories
Revenue for Genmab (GMAB)
Revenue in 2024 (TTM): C$4.28 Billion
According to Genmab's latest financial reports the company's current revenue (TTM 
) is C$4.33 Billion. an increase over the revenue in the year 2023 that were of C$3.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Genmab from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | C$4.45 B | 40.96% |
| 2023 | C$3.16 B | 13.39% |
| 2022 | C$2.78 B | 65.26% |
| 2021 | C$1.68 B | -15.4% |
| 2020 | C$1.99 B | 90.15% |
| 2019 | C$1.04 B | 62.14% |
| 2018 | C$0.64 B | 38.91% |
| 2017 | C$0.46 B | 30.77% |
| 2016 | C$0.35 B | 53.05% |
| 2015 | C$0.23 B | 35.22% |
| 2014 | C$0.17 B | 36.27% |
| 2013 | C$0.12 B | 49.9% |
| 2012 | C$84.24 M | 27.72% |
| 2011 | C$65.95 M | -35.77% |
| 2010 | C$0.10 B | -10.63% |
| 2009 | C$0.11 B |